commitments from over 20 faculty. Anne Harrington will be joining us. We recently published an physiological study of placebo in the New England Journal of Medicine and a theoretical paper in Philosophic Transactions of the Roy Soc B. (I'm attaching fyi). We anticipate making some major breakthroughs in geneti

fficiently. This spirit of cooperation was covered thoughtfully in a recent New England 6 CONTROL NUMBER 257 - CONFIDENTIAL HOUSE_OVERSIGHT_024017 Journal of Medicine editorial (November 2013), where Janet Woodcock, MD, the FDA’s Director of the Center for Drug Evaluation and Research and other senior FDA staff mem